Chronic mild stress-induced anhedonia: A realistic animal model of depression

Neuroscience and Biobehavioral Reviews

Volumn 16, Issue 4, 1992, Pages 525-534

  Willner, Paul ^a   Muscat, Richard ^a   Papp, Mariusz ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Anhedonia; Animal model of depression; Chronic mild stress; Construct validity; D2 receptors; Dopamine; Face validity; Nucleus accumbens; Predictive validity; Sensitization

Indexed keywords

CENTRAL STIMULANT AGENT; CLOMIPRAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR;

ANIMAL MODEL; BEHAVIOR; DEPRESSION; LEARNING; NONHUMAN; NUCLEUS ACCUMBENS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REVIEW; SHOCK; STRESS;

ANIMAL; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; REWARD; STRESS, PSYCHOLOGICAL; SUPPORT, NON-U.S. GOV'T;

EID: 0026440178     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(05)80194-0     Document Type: Article

References (118)

1. Modeling psychopathology in the laboratory: History and rationale
2. Stress and depression: A test of the buffering model of social support
3. Reward system depression following chronic amphetamine: Antagonism by haloperidol
4. Quantifying palatability in humans
5. Social-environmental factors in unipolar depression: Comparisons of depressed patients and non-depressed controls
6. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats: Possible implication in the behavioural mechanism of action of antidepressants
7. Response to stress of mesocortical frontal dopaminergic neurons in rats after long-term isolation
8. The mesolimbic dopamine system as a model reward system
9. Serotoninmimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats
10. A psychosocial view of depression
11. Conditioned place preference as a measure of drug reward
12. Amphetamine withdrawal effects threshold of intracranial self-stimulation
13. Changes in dopamine sensitivity in rats selectively bred for difference in cholinergic function
14. The microstructure of ingestive behavior
15. Clinical evidence for a role of dopaminergic systems in depressive syndromes
16. Stress-related activation of cerebral dopaminergic systems
17. Animal models with construct validity for schizophrenia
18. Depressive reactions and unemployment
19. Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats
20. Learned helplessness, stress and the depressive disorders
21. Antidepressants selectively antagonize the hyperactivity induced in rats by long-term social isolation
22. Which endogenous depressive symptoms relate to REM latency reduction?
23. Animal models of drug abuse and dependence
24. Animal models of anxiety
25. Animal models in psychiatry
26. The impact of unemployment in the 1930s and the 1970s
27. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine
28. Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events
29. Animal model of depression: Pharmacological sensitivity of a hedonic deficit
30. Animal model of depression: Tests of three structurally and pharmacologically novel antidepressant compounds
31. Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression
32. Repeated administration of antidepressant drugs enhanced agonist affinity for mesolimbic D-2 receptors
33. Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm
34. Post-amphetamine depression of self-stimulation responding from the substantia nigra: Reversal by tricyclic antidepressants
35. Anhedonia as an animal model of depression
36. Neuroanatomical substrates of drug self-administration
37. Reward and detection thresholds for brain stimulation Dissociative effects of cocaine
38. The use of the sleep laboratory in the diagnosis of affective disorders
39. Amphetamine and the reward system: Evidence for tolerance and post-drug depression
40. A behavioral approach to depression
41. Life events and depressive disorders reviewed
42. Learned helplessness and animal models of depression. Prog. Neuropsychopharmacol
43. Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system
44. Bromocriptine reverses post-cocaine anhedonia in a rat model of cocaine withdrawal
45. Effects of performance and reward manipulations on current-intensity thresholds and other measures derived from a discrete-trial self-stimulation procedure in rats
46. Conditioning and experiential factors affecting the development of sensitization to apomorphine
47. Animal model of depression: Review of evidence and implications for research
48. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behavior in rats
49. Marqueurs polygraphiques, cliniques et thérapeutiques des depressions dopamino-dépendantes (DDD)
50. La L-tyrosine guérit, immediatement et a long terme, les depressions dopamino-dépendantes (DDD). Étude clinique et polygraphique
51. Suppression of sucrose drinking by chronic mild unpredictable stress: A methodological analysis
52. Sweetness-dependent facilitation of sucrose drinking by raclopride is unrelated to calorie content
53. Antidepressant-like actions of dopamine agonists in an animal model of depression
54. Dopaminergic mechanism of imipramine action in an animal model of depression
55. Changes in dopamine autoreceptor sensitivity in an animal model of depression
56. The use of antipsychotic drugs in the treatment of depression
57. The symptoms of major depression
58. A cholinergic supersensitivity model of depression
59. Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress
60. Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist
61. An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
62. Neuroanatomical bases of intracranial self-stimulation: Untangling the Gordian knot
63. Different anatomical substrates for neuroleptic-induced response decrement and neuroleptic-induced anhedonia
64. Reward-dependent suppression or facilitation of consummatory behaviour by raclopride
65. MIF-I is active in a chronic stress animal model of depression
66. Restraint stress-induced changes in saccharin preference: the effect of antidepressant treatments and diazepam
67. Behavioral despair in rats and mice: Strain differences and the effects of imipramine
68. Pharmacological models of depression
69. Animal models of mania
70. Effects of acute and chronic stressors on saccharin preference in hypercholinergic rats
71. Current pharmacotherapy of anxiety and panic
72. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
73. Decreased reactivity to sweetness following chronic exposure to mild unpredictable stress or acute administration of pimozide
74. Reversal of antidepressant action by dopamine antagonists in an animal model of depression
75. Hedonic response of rats to polysaccharide and sugar solutions
76. Seiden, L. S.; Dahms, J. L.; Shaughnessy, R. A. Behavioral screen for antidepressants: The effects of drugs and electrocon-vulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology 86:55–60.
77. Stressor-provoked behavioral changes in six strains of mice
78. Specificity of the learned helplessness model of depression
79. Behavioural withdrawal following several psychoactive drugs
80. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
81. Reconciling the role of central serotonin neurons in human and animal behavior
82. Attenuation by haloperidol of place preference conditioning using food reinforcement
83. Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine
84. Selective activation of the mesocortical dopamine system by stress
85. A new animal model of endogenous depression: A summary of present findings
86. Decreased intracranial self-stimulation in a new animal model of endogenous depression
87. Sham feeding as a procedure for assessing the influence of diet palatability on food intake
88. A model for the neurochemical study of depression
89. The validity of animal models of depression
90. Validating criteria for animal models of human mental disorders: Learned helplessness as a paradigm case. Progress in Neuropsychopharmacol
91. Sensitization to the actions of antidepressant drugs
92. Towards a theory of serotonergic dysfunction in depression
93. Animal models of depression: An overview
94. Animal models as simulations of depression
95. Changes in mesolimbic dopamine may explain stress-induced anhedonia
96. Dopamine, depression and antidepressant drugs
97. Environmental influences on behavioural sensitization to the dopamine agonist quinpirole
98. Suppression of rewarded behaviour by neuroleptic drugs: Can't or won't, and why?
99. Animal models of anhedonia
100. Effects of isolated housing and chronic antidepressant treatment on cooperative social behaviour in rats
101. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant
102. Attributional style and perceived stress in endogenous and reactive depression
103. Neuroleptics and operant behaviour The anhedonia hypothesis
104. The brain and reward
105. Stress-induced changes in daily activity in the rat are modulated by different factors than are stress-induced escape-learning deficits
106. Stressor-provoked alterations of intracranial self-stimulation in the mesocortiolimbic dopamine system: An animal model of depression
107. Responding for brain stimulation: Stress and desmethylimipramine. Progress in Neuropsychopharmacol
108. Region specific reductions of intracranial self-stimulation after uncontrollable stress: Possible effects on reward processes
109. Strain specific effects of inescapable shock on intracranial self-stimulation from the nucleus accumbens
110. Melancholia: From DSM-III to DSM-III-R